Narendra Krishnani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Narendra Krishnani has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Akash Mathur
Department of Gastroenterology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
1 shared publication - Akshay Kulkarni
Midas Multi-Speciality Hospital, Nagpur, Maharashtra, India
1 shared publication - Anjali Mishra
Department of Endocrine Surgery Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
1 shared publication - Anshu Srivastava
Department of Pediatric Gastroenterology Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
1 shared publication - Gaurav Agarwal
Department of Endocrine Surgery Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
1 shared publication - Niloy Ranjan Datta
Department of Radiotherapy, Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha, Maharashtra, India
1 shared publication
Latest Publications
- 15 January 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (2) , 250-257
Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
Background Molecular sub-characterization of triple-negative breast cancer (TNBC) has great therapeutic and possibly prognostic implications. The primary aim of this study was to investigate the incidence of luminal androgen receptor (LAR) subtype of TNBC and secondary aims were sub-categorization and clinico-pathologic correlation of LAR breast cancers. Retrospective study (January 2008 and 31st of December 2018) consisting of 157 TNBC patients. Androgen receptor (AR) expression was measured by immunohistochemical analysis. One percent cutoff was set as a positive expression. Sub-categorization was done on the basis of EGFR (> 15% of tumor cells) and Ki-67 expression (low- < 11%, intermediate- 11–20%, and high- > 21%). AR expression was correlated with various clinico-pathologic features and outcomes of the patients. The incidence of AR expression in TNBC was 24.8%. Considering different thresholds of > 5%, > 10%, and > 20% immunostaining, the incidence of AR positivity was 18.4, 15.2, and 11.5% respectively. The incidence of Ki-67 (p = 0.89) and EGFR (p = 0.643) expression did not differ significantly in AR-positive and -negative TNBC. Based on EGFR expression 19, 67 and 14% patients were categorized as low, intermediate, and high risk respectively. Low-risk (p ≤ 0.001) and low-grade (p = 0.014) tumors were more likely to have > 10% AR expression. Clinico-pathological profile, response to neoadjuvant chemotherapy, disease-free survival (p = 0.458), and overall survival (p = 0.806) did not significantly differ between AR expressing and negative TNBC. On multivariate analysis, only tumor staging was a significant predictor of survival (p = 0.012) and AR expression of > 10% revealed a trend towards improved survival (p = 0.07). When considering only AR-positive TNBC, AR expression of > 10% (p = 0.038), distant metastases (p = 0.003), and EGFR status (p = 0.024) were significantly associated with survival. AR expression does not seem to very strongly correlate with prognosis in TNBC and further studies could focus more on its predictive role in deciding anti-androgen therapy.
- 15 January 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (2) , 250-257
Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
Background Molecular sub-characterization of triple-negative breast cancer (TNBC) has great therapeutic and possibly prognostic implications. The primary aim of this study was to investigate the incidence of luminal androgen receptor (LAR) subtype of TNBC and secondary aims were sub-categorization and clinico-pathologic correlation of LAR breast cancers. Retrospective study (January 2008 and 31st of December 2018) consisting of 157 TNBC patients. Androgen receptor (AR) expression was measured by immunohistochemical analysis. One percent cutoff was set as a positive expression. Sub-categorization was done on the basis of EGFR (> 15% of tumor cells) and Ki-67 expression (low- < 11%, intermediate- 11–20%, and high- > 21%). AR expression was correlated with various clinico-pathologic features and outcomes of the patients. The incidence of AR expression in TNBC was 24.8%. Considering different thresholds of > 5%, > 10%, and > 20% immunostaining, the incidence of AR positivity was 18.4, 15.2, and 11.5% respectively. The incidence of Ki-67 (p = 0.89) and EGFR (p = 0.643) expression did not differ significantly in AR-positive and -negative TNBC. Based on EGFR expression 19, 67 and 14% patients were categorized as low, intermediate, and high risk respectively. Low-risk (p ≤ 0.001) and low-grade (p = 0.014) tumors were more likely to have > 10% AR expression. Clinico-pathological profile, response to neoadjuvant chemotherapy, disease-free survival (p = 0.458), and overall survival (p = 0.806) did not significantly differ between AR expressing and negative TNBC. On multivariate analysis, only tumor staging was a significant predictor of survival (p = 0.012) and AR expression of > 10% revealed a trend towards improved survival (p = 0.07). When considering only AR-positive TNBC, AR expression of > 10% (p = 0.038), distant metastases (p = 0.003), and EGFR status (p = 0.024) were significantly associated with survival. AR expression does not seem to very strongly correlate with prognosis in TNBC and further studies could focus more on its predictive role in deciding anti-androgen therapy.
- 26 May 2023
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 13 (6) , 1156-1158
Frequency of Non-cirrhotic Portal Fibrosis in Patients with Celiac Disease: A Single Center Experience From Northern India
- 26 May 2023
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 13 (6) , 1156-1158
Frequency of Non-cirrhotic Portal Fibrosis in Patients with Celiac Disease: A Single Center Experience From Northern India
- 21 January 2020
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 179 (4) , 671-677
Utility and accuracy of transient elastography in determining liver fibrosis: a case-control study
The objectives of this prospective case-control study were to determine liver stiffness (LSM) by transient elastography (TE) in children with newly diagnosed chronic liver disease (CLD) and to find out normal values in healthy Indian children. Two groups (A: 50 CLD who underwent liver biopsy and B: 50 healthy) aged 5–18 years were recruited prospectively. Liver biopsies were scored as per Metavir scoring and compared with TE. The median age of 100 recruited children was 13.6 years. In group B, normal LSM was 4.9 (2.5–7.3) kPa with significantly higher LSM in adolescent males (5.6 (4.1–7.3) kPa) as compared with females (4.3 (3.7–4.9) kPa), p = 0.001. In group A, TE was excellent in discriminating significant fibrosis (≥ F2) (P = 0.001) at a cut-off value of 10.6 kPa with area under receiver operating characteristic curve of 0.96. Metavir fibrosis stage (β = 0.611; R2 = 0.586) and age (β = 0.230; R2 = 0.586) were independent variables associated with higher LSM in stepwise multiple logistic regression analysis.
- 21 January 2020
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 179 (4) , 671-677
Utility and accuracy of transient elastography in determining liver fibrosis: a case-control study
The objectives of this prospective case-control study were to determine liver stiffness (LSM) by transient elastography (TE) in children with newly diagnosed chronic liver disease (CLD) and to find out normal values in healthy Indian children. Two groups (A: 50 CLD who underwent liver biopsy and B: 50 healthy) aged 5–18 years were recruited prospectively. Liver biopsies were scored as per Metavir scoring and compared with TE. The median age of 100 recruited children was 13.6 years. In group B, normal LSM was 4.9 (2.5–7.3) kPa with significantly higher LSM in adolescent males (5.6 (4.1–7.3) kPa) as compared with females (4.3 (3.7–4.9) kPa), p = 0.001. In group A, TE was excellent in discriminating significant fibrosis (≥ F2) (P = 0.001) at a cut-off value of 10.6 kPa with area under receiver operating characteristic curve of 0.96. Metavir fibrosis stage (β = 0.611; R2 = 0.586) and age (β = 0.230; R2 = 0.586) were independent variables associated with higher LSM in stepwise multiple logistic regression analysis.
- 14 September 2016
- Published by Morressier GmbH
Clinicopathological features in large parathyroid adenomas: A study from India
- 14 September 2016
- Published by Morressier GmbH
Clinicopathological features in large parathyroid adenomas: A study from India
- 1 June 2005
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (3) , 764-771
Radiation therapy induced micronuclei in cervical cancer—does it have a predictive value for local disease control?
- 1 June 2005
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (3) , 764-771
Radiation therapy induced micronuclei in cervical cancer—does it have a predictive value for local disease control?